secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001104659-25-039710
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics enters $2.5B revolving credit facility, repays $200M of existing debt
--------------------------------------------------------------------------------

- New $2.5B unsecured revolving credit facility, with option to increase by up to $750M.
- Borrowed $200M at closing to repay outstanding indebtedness under 2022 credit agreement.
- Five-year maturity, with two potential one-year extensions at lenders' option.
- Financial covenants: consolidated total leverage ≤3.50x and interest coverage ≥3.00x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465925039710/0001104659-25-039710-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465925039710/tm2512890d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-039710

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer